|
1,195
|
| 7971 |
Emodin
|
|
decreases_phosphorylation of
|
ERBB2
|
|
|
18301953
|
Schizophrenia
|
|
2,897
|
| 26603 |
Metformin
|
|
decreases_expression of
|
ERBB2
|
|
| 26623 |
Metformin
|
|
decreases_activity of
|
ERBB2
|
|
|
19221498
|
Breast cancer
Diabetes mellitus, type II
Insulin resistance
|
|
4,197
|
| 43075 |
Streptozocin-induced diabetes
|
|
decreases_expression of
|
ERBB2
|
in cardiac muscle
|
| 43079 |
Streptozocin-induced diabetes
|
|
decreases_phosphorylation of
|
ERBB2
|
in cardiac muscle
|
|
22285193
|
Diabetes mellitus, type II
Diabetes mellitus, type I
Insulin resistance
Cardiomyopathy, diabetic
|
|
4,198
|
| 43085 |
muscle contraction
|
|
increases_phosphorylation of
|
ERBB2
|
in skeletal muscle
|
|
16740635
|
Diabetes mellitus, type II
Insulin resistance
|
|
4,617
|
| 46016 |
ERBB2
|
|
affects_activity of
|
ERBB signaling pathway
|
|
|
9247128
|
Metabolic
Sleep disorders
|
|
5,101
|
| 50163 |
ERBB2
|
|
affects_activity of
|
neoplasm
|
|
| 50165 |
ERBB2
|
|
affects_expression of
|
ESR1
|
|
| 50167 |
ERBB2
|
|
affects_activity of
|
ESR1
|
|
|
17138652
|
Cancer
|
|
5,520
|
| 53476 |
ILK
|
|
affects_expression of
|
ERBB2
|
via TWIST and YB-1
|
|
20838384
|
Metabolic
|
|
5,521
|
| 53478 |
ERBB2
|
|
increases_expression of
|
EGFR
|
|
| 53479 |
ERBB2
|
|
increases_expression of
|
EIF4EBP1
|
|
|
22912742
|
Cardiomyopathy, hypertrophic
|
|
5,522
|
| 53480 |
ERBB2
|
|
increases_phosphorylation of
|
EMD
|
|
|
19789182
|
Metabolic
|
|
5,620
|
| 53798 |
ILK
|
|
affects_expression of
|
ERBB2
|
in breast cancer cells
|
|
20838384
|
Breast cancer
|
|
5,621
|
| 53799 |
ERBB2
|
|
increases_phosphorylation of
|
EMD
|
|
|
16785428
|
Breast cancer
Metabolic
|
|
5,949
|
| 56065 |
ERBB2
|
|
affects_expression of
|
MUC6
|
in gastric cancer tissue
|
|
26060493
|
Metabolic
Gastric cancer
|
|
6,278
|
| 58768 |
ERBB2
|
|
affects_activity of
|
Glioblastoma
|
|
|
|
Glioblastoma
|
|
6,363
|
| 59903 |
hexosamine biosynthetic pathway
|
|
affects_activity of
|
ERBB2
|
|
|
26164081
|
Diabetes mellitus, type II
Pancreatic cancer
Insulin resistance
|
|
6,456
|
| 61393 |
RPS6KB1
|
|
increases_expression of
|
ERBB2
|
|
| 61394 |
ERBB2
|
|
increases_activity of
|
Cancer
|
|
|
22117616
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
6,646
|
| 64116 |
ERBB2
|
|
affects_activity of
|
neoplasm
|
|
|
25672512
|
Cancer
|
|
9,936
|
| 104050 |
ERBB2
|
|
affects_expression of
|
HECTD3
|
|
| 104051 |
ERBB2
|
|
affects_expression of
|
STAT3
|
|
|
28989055
|
Breast cancer
Esophageal cancer
Ovarian cancer
|
|
10,654
|
| 109087 |
MEMO1
|
|
interacts (colocalizes) with
|
ERBB2
|
|
|
15156151
|
Cancer
|
|
12,841
|
| 123245 |
CFTR
|
|
affects_expression of
|
ERBB2
|
via YBX3
|
|
25107366
|
Infertility
|
|
12,842
|
| 123255 |
YBX3
|
|
affects_expression of
|
ERBB2
|
|
| 123256 |
TJP1
|
|
affects_expression of
|
ERBB2
|
|
|
10790369
|
Cancer
|
|
13,516
|
| 127438 |
Angiotensin (1-7)
|
|
decreases_activity of
|
ERBB2
|
via decreased phosphorylation
|
| 127453 |
Diabetes mellitus
|
|
increases_activity of
|
ERBB2
|
via phosphorylation
|
| 127462 |
hyperglycemia
|
|
increases_activity of
|
ERBB2
|
in aortic smooth muscle cells
|
| 127463 |
Angiotensin (1-7)
|
|
decreases_activity of
|
ERBB2
|
in aortic smooth muscle cells
|
| 127465 |
MAS1
|
|
decreases_activity of
|
ERBB2
|
in aortic smooth muscle cells
|
|
26536590
|
Diabetes mellitus, type II
Insulin resistance
|
|
13,763
|
| 129320 |
ERBB2
|
|
affects_activity of
|
Cancer
|
|
| 129324 |
ERBB2
|
|
increases_activity of
|
cell differentiation
|
|
| 129355 |
ERBB3
|
|
increases_activity of
|
ERBB2
|
|
| 129356 |
ERBB3
|
|
interacts (colocalizes) with
|
ERBB2
|
|
|
24520092
|
Cancer
|
|
14,832
|
| 139242 |
PEPD
|
|
interacts (colocalizes) with
|
ERBB2
|
|
| 139243 |
PEPD
|
|
affects_activity of
|
ERBB2
|
|
|
24810047
|
Cancer
|
CIDeRplus